Anna Shmagel

6.0k total citations · 1 hit paper
23 papers, 1.1k citations indexed

About

Anna Shmagel is a scholar working on Rheumatology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Anna Shmagel has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 7 papers in Hematology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Anna Shmagel's work include Autoimmune and Inflammatory Disorders Research (7 papers), Systemic Lupus Erythematosus Research (5 papers) and Rheumatoid Arthritis Research and Therapies (5 papers). Anna Shmagel is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (7 papers), Systemic Lupus Erythematosus Research (5 papers) and Rheumatoid Arthritis Research and Therapies (5 papers). Anna Shmagel collaborates with scholars based in United States, Germany and Japan. Anna Shmagel's co-authors include Robert N. Foley, Abigail J. Johnson, Kristine E. Ensrud, Dan Knights, Tonya Ward, Ravi S. Menon, Benjamin Hillmann, Robin Shields‐Cutler, Pajau Vangay and Katie Koecher and has published in prestigious journals such as Spine, Annals of the Rheumatic Diseases and Cell Host & Microbe.

In The Last Decade

Anna Shmagel

22 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Daily Sampling Reveals Personalized Diet-Microbiome Associations in Humans

2019 474 citations Abigail J. Johnson, Pajau Vangay et al. Cell Host & Microbe profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Shmagel United States	11	456	327	319	174	124	23	1.1k
Melainie Cameron Australia	18	164 0.4×	401 1.2×	119 0.4×	81 0.5×	138 1.1×	57	1.4k
Shigeyuki Nakaji Japan	23	427 0.9×	127 0.4×	340 1.1×	102 0.6×	97 0.8×	78	1.5k
Djawad Radjabzadeh Netherlands	14	924 2.0×	68 0.2×	431 1.4×	88 0.5×	39 0.3×	23	1.3k
Adriana Coppola Italy	16	459 1.0×	77 0.2×	271 0.8×	95 0.5×	40 0.3×	40	1.4k
Dominique Moyse France	23	267 0.6×	112 0.3×	160 0.5×	76 0.4×	187 1.5×	50	2.3k
Negar Naderpoor Australia	20	607 1.3×	73 0.2×	493 1.5×	418 2.4×	449 3.6×	38	1.8k
Tricia D. LeVan United States	23	290 0.6×	62 0.2×	322 1.0×	182 1.0×	36 0.3×	53	1.7k
Dug Yeo Han New Zealand	21	314 0.7×	42 0.1×	173 0.5×	330 1.9×	61 0.5×	54	1.5k
Masakazu Nakamura Japan	18	669 1.5×	39 0.1×	580 1.8×	280 1.6×	371 3.0×	42	1.9k
Javier Romeo Spain	20	163 0.4×	49 0.1×	370 1.2×	320 1.8×	210 1.7×	29	1.4k

Countries citing papers authored by Anna Shmagel

Since Specialization

Citations

This map shows the geographic impact of Anna Shmagel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Shmagel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Shmagel more than expected).

Fields of papers citing papers by Anna Shmagel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Shmagel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Shmagel. The network helps show where Anna Shmagel may publish in the future.

Co-authorship network of co-authors of Anna Shmagel

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Shmagel. A scholar is included among the top collaborators of Anna Shmagel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Shmagel. Anna Shmagel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bosch, Filip Van den, Atul Deodhar, Denis Poddubnyy, et al.. (2025). Upadacitinib in active non-radiographic axial spondyloarthritis: 2-year data from the phase 3 SELECT-AXIS 2 study. Arthritis Research & Therapy. 27(1). 23–23.

Brunner, Hermine I., Anna Shmagel, Gerd Horneff, et al.. (2024). Pharmacokinetics, Efficacy, and Safety of Upadacitinib in Pediatric Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis: An Interim Analysis of an Open‐Label, Phase 1 Trial. Arthritis Care & Research. 77(5). 584–593. 4 indexed citations

Burmester, Gerd R, Filip Van den Bosch, John Tesser, et al.. (2024). Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT). The Journal of Rheumatology. 51(7). 663–672. 3 indexed citations

Baraliakos, Xenofon, J. Sieper, Robert D. Inman, et al.. (2024). Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis refractory to biologic therapy: 2-year clinical and radiographic results from the open-label extension of the SELECT-AXIS 2 study. Arthritis Research & Therapy. 26(1). 197–197. 2 indexed citations

Qian, Yuli, et al.. (2024). Extrapolation of Upadacitinib Efficacy in Juvenile Idiopathic Arthritis Leveraging Pharmacokinetics, Exposure–Response Models, and Real‐World Patient Data. Clinical Pharmacology & Therapeutics. 116(6). 1635–1645. 5 indexed citations

Charles‐Schoeman, Christina, Ernest Choy, Iain B. McInnes, et al.. (2023). MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. RMD Open. 9(4). e003392–e003392. 17 indexed citations

Baraliakos, Xenofon, Désirée van der Heijde, Joachim Sieper, et al.. (2023). Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study. Arthritis Research & Therapy. 25(1). 172–172. 12 indexed citations

Johnson, Abigail J., Pajau Vangay, Gabriel A. Al‐Ghalith, et al.. (2019). Daily Sampling Reveals Personalized Diet-Microbiome Associations in Humans. Cell Host & Microbe. 25(6). 789–802.e5. 474 indexed citations breakdown →

Langsetmo, Lisa, Abigail J. Johnson, Ryan T. Demmer, et al.. (2019). The Association between Objectively Measured Physical Activity and the Gut Microbiome among Older Community Dwelling Men. The journal of nutrition health & aging. 23(6). 538–546. 36 indexed citations

10.

Shmagel, Anna, Lisa Langsetmo, Ryan T. Demmer, et al.. (2019). Gut microbiome associations with chronic musculoskeletal pain in older men. Osteoarthritis and Cartilage. 27. S73–S73. 6 indexed citations

11.

Shmagel, Anna, Ryan T. Demmer, Mary Butler, et al.. (2019). The Effects of Glucosamine and Chondroitin Sulfate on Gut Microbial Composition: A Systematic Review of Evidence from Animal and Human Studies. Nutrients. 11(2). 294–294. 53 indexed citations

12.

Shmagel, Anna, et al.. (2018). Low magnesium intake is associated with increased knee pain in subjects with radiographic knee osteoarthritis: data from the Osteoarthritis Initiative. Osteoarthritis and Cartilage. 26(5). 651–658. 44 indexed citations

13.

Shmagel, Anna, et al.. (2018). Prescription Medication Use Among Community-Based U.S. Adults With Chronic Low Back Pain: A Cross-Sectional Population Based Study. Journal of Pain. 19(10). 1104–1112. 53 indexed citations

14.

Titcombe, Philip J., Gustaf Wigerblad, Natalie Sippl, et al.. (2018). Pathogenic Citrulline‐Multispecific B Cell Receptor Clades in Rheumatoid Arthritis. Arthritis & Rheumatology. 70(12). 1933–1945. 52 indexed citations

15.

Shmagel, Anna, et al.. (2018). Population-Wide Associations between Common Viral Pathogens and Self-Reported Arthritis: NHANES 2009-2012. International Journal of Rheumatology. 2018. 1–7. 1 indexed citations

16.

Shmagel, Anna, et al.. (2017). SAT0484 Low magnesium intake is associated with increased pain in subjects with radiographic knee osteoarthritis: data from the osteoarthritis initiative. Annals of the Rheumatic Diseases. 76. 958–959. 1 indexed citations

17.

Shmagel, Anna, Erin E. Krebs, Kristine E. Ensrud, & Robert N. Foley. (2016). Illicit Substance Use in US Adults With Chronic Low Back Pain. Spine. 41(17). 1372–1377. 27 indexed citations

18.

Shmagel, Anna, et al.. (2016). Epidemiology of Chronic Low Back Pain in US Adults: Data From the 2009–2010 National Health and Nutrition Examination Survey. Arthritis Care & Research. 68(11). 1688–1694. 289 indexed citations

19.

Amara, Khaled, Akilan Krishnamurthy, Anna Shmagel, et al.. (2016). A2.33 Citrullinated self antigen-specific blood B cells carry cross-reactive immunoglobulins with effector potential. Annals of the Rheumatic Diseases. 75. A28–A29. 4 indexed citations

20.

Shmagel, Anna, et al.. (2011). Granulomatosis With Polyangiitis (Wegener’s) Presenting as a Periaortic Mass. JCR Journal of Clinical Rheumatology. 17(8). 442–443. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact